United States-based AMPAC Fine Chemicals announced yesterday that it has named Joe Warchol as its new chief financial officer.

Warchol will be responsible for all aspects of financial management across all the company's sites.

He has most recently been the executive director, US Business Operations at AMGEN. In that role, he guided that division through significant strategic planning to address patent expiry while simultaneously launching several new products. Prior to that, he led finance for GSK's US Primary Care and Vaccine divisions. From 1990 until 2009, Warchol held numerous roles of increasing responsibility at Wyeth Pharmaceuticals, across Commercial, Supply Chain, and R&D.